Anti TB Flashcards

1
Q

What is the mechanism of action of Rifampicin?

A

Rifampicin inhibits the gene transcription of mycobacteria by blocking the DNA- dependent RNA polymerase, which prevents the bacillus from synthesizing messenger RNA and protein, causing cell death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How does resistance to rifampicin occur?

A

mutations in the gene, which encodes the RNA polymerase beta chain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is Rifampicin used for?

A

Active and latent TB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ROA of Rifampicin?

A

Oral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which out of RIPE is hepatotoxic?

A

R, I, P. P is the most hepatotoxic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Can Rifampicin be used in pregnancy? What must be given to the mother and neonate?

A

Rifampicin is a category C drug. It has been used during pregnancy, and no teratogenic effects have been reported. As a precaution, mothers, and neonates born to mothers who have been under treatment with rifampicin should be given vitamin K, in order to avoid postpartum haemorrhage (as an adverse effect associated with rifampicin is thrombocytopenia).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which out of RIPE are safe for the kidney?

A

R and I.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Use of Rifampicin in kidney failure?

A

No dose adjustment needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Use of Rifampicin in liver failure?

A

Used when benefits outweighs risk. Liver functioning must be closely monitored

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Does Rifampicin have DDI?

A

Yes, it INDUCES cyp450 enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the adverse effects of Rifampicin?

A
  1. Hepatitis
  2. Drug interactions due to induction of CYP enzymes
  3. Orange discolouration of bodily fluids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the mechanism of action of isoniazid?

A

Isoniazid is a prodrug. It is activated by the catalase-peroxidase enzyme of M. tuberculosis. The activation of isoniazid produces oxygen-derived free radicals that can inhibit the formation of mycolic acids of the bacterial cell wall, cause DNA damage and, subsequently, the death of the bacillus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the mechanisms of resistance to Isoniazid?

A

mutations to the catalase-peroxidase enzyme, and mutations of the regulatory genes involved in mycolic acid synthesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is Isoniazid used for?

A

Active and latent TB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How is isoniazid administered?

A

Oral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is isoniazid metabolized?

A

Metabolized in the liver through acetylation by N-acetyltransferase. Excreted by the kidney as mainly inactive metabolites.

The acetylation rate is related to genetic polymorphisms.

17
Q

Use of isoniazid in liver failure?

A

These patients should be closely monitored and should undergo clinical examination and laboratory tests more frequently than is necessary for patients without liver disease.

18
Q

Use of isoniazid in kidney failure?

A

No dose adjustment is needed in patients with renal impairment

19
Q

What is pyridoxine used for?

A

Together with isoniazid to prevent pyridoxine deficiency and peripheral neuropathy

20
Q

What should isoniazid not be taken with?

A

Isoniazid should NOT be taken concomitantly with foods rich in tyramine and histamine

21
Q

Does isoniazid have DDI?

A

Yes, it inhibits CYP450.

22
Q

Key adverse effects of isoniazid?

A
  1. Peripheral neuropathy - take pyridoxine

2. Hepatitis

23
Q

What is pyrazinamide useful against?

A

Persisters. This activity of pyrazinamide allows the duration of the treatment with rifampicin, isoniazid and pyrazinamide to be reduced to six months.

24
Q

MOA of pyrazinamide

A

Pyrazinamide is a prodrug that needs to be converted into its active form, pyrazinoic acid, by the microbial enzymes pyrazinamidase.
It is supposed that pyrazinamide enters the bacillus passively, is converted into pyrazinoic acid by pyrazinamidase, and reaches high concentrations in the bacterial cytoplasm. The accumulation of pyrazinoic acid decreases the intracellular pH to levels that cause the inactivation of critical pathways necessary for the survival of the bacteria.

25
Q

Resistance to pyrazinamide

A

mutations in the gene, which encodes the pyrazinamidase enzyme and prevents pyrazinamide from being converted into its active form.

26
Q

What is pyrazinamide used for

A

Active TB

27
Q

Use of pyrazinamide in liver and kidney failure?

A

Avoid in patients with liver disease. Dose adjust for kidney failure

28
Q

Adverse effects of pyrazinamide

A
  1. Hepatotoxicity
  2. Hyperuricemia and arthralgia: Pyrazinoic acid, the principal metabolite of
    pyrazinamide, inhibits the renal tubular secretion of uric acid and results in
    gout like symptoms. (Observed more with pyrazinamide then with
    ethambutol.)
29
Q

MOA of ethambutol?

A

Ethambutol inhibits the arabinosyltransferase enzyme encoded by the embB gene and interferes with the polymerization of arabinose into arabinogalactan, the principal polysaccharide on the mycobacterial cell wall.
This affects the integrity of the Mycobacterium tuberculosis cell wall and thus facilitates the entry of lipophilic antibiotics, like rifampicin and levofloxacin.

30
Q

Adverse effects of ethambutol

A
  1. Visual toxicity

2. Hyperuricemia/gout

31
Q

Use of ethambutol for liver failure and kidney failuRe

A

Use in patients with liver failure : Ethambutol can be used at full doses in patients with liver failure

Use in patients with kidney failure: Dose reduction. Ethambutol and its metabolites can accumulate in patients with kidney failure.